Elevance Health Corporate & Other — Operating revenue - total decreased by 97.3% to $4.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 97.6%, from $165.00M to $4.00M. Over 2 years (FY 2022 to FY 2024), Corporate & Other — Operating revenue - total shows a downward trend with a -8.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Growth in this metric indicates expansion of non-core business activities, while a decline suggests consolidation or divestiture of these units.
This metric aggregates all operating revenue generated by the corporate and other segment, including premiums, service f...
Comparable to 'corporate segment revenue' or 'other segment revenue' in peer financial disclosures.
elv_segment_corporate_other_operating_revenue_total| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $99.75M | $99.75M | $99.75M | $99.75M | $119.75M | $119.75M | $119.75M | $119.75M | $127.00M | $122.00M | $84.00M | $0.00 | $165.00M | $232.00M | $149.00M | $4.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +20.1% | +0.0% | +0.0% | +0.0% | +6.1% | -3.9% | -31.1% | -100.0% | — | +40.6% | -35.8% | -97.3% |
| YoY Change | — | — | — | — | +20.1% | +20.1% | +20.1% | +20.1% | +6.1% | +1.9% | -29.9% | -100.0% | +29.9% | +90.2% | +77.4% | -97.6% |